Related Experiment Video

Updated: Oct 24, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.5K

Coronavirus Disease in Children: A Single-Center Study from Western Saudi Arabia

Rafat M Mosalli1,2, Sumayyah Ahmed Nezar Kobeisy3, Nawaf M Al-Dajani2,4

  • 1Department of Pediatrics, Umm Al Qura University, Makkah, Saudi Arabia.

International Journal of Pediatrics
|August 16, 2021
PubMed

Insights

Pediatric COVID-19 in Saudi Arabia often presents with fever and respiratory symptoms. Most children experience mild illness, but further research is needed to identify at-risk cases.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Public Health

Background:

  • Limited data exists on pediatric SARS-CoV-2 infections in Saudi Arabia.
  • Understanding the impact of COVID-19 on children is crucial.

Purpose of the Study:

  • To investigate the clinical presentation, laboratory findings, and outcomes of pediatric COVID-19 patients.
  • To add insight into the effects of the novel coronavirus on children in Jeddah, Saudi Arabia.

Main Methods:

  • Retrospective study conducted at a single center in Jeddah, Saudi Arabia.
  • Analysis of pediatric patients admitted with COVID-19 between April 2020 and September 2020.
  • Inclusion criteria applied to identify relevant patient data.

Main Results:

  • 43 pediatric patients met the inclusion criteria.
  • Fever (53.5%) was the most common symptom, followed by cough, runny nose, and shortness of breath (37.2%).
  • Lymphocytopenia (60%) and elevated C-Reactive Protein (24.9%) were observed. Over half (53.5%) required only supportive care.

Conclusions:

  • COVID-19 in children is generally mild with varied clinical and nonspecific laboratory findings.
  • Large-scale national studies are necessary for early identification of at-risk pediatric cases.
  • Further research can inform timely management, population-specific patterns, and targeted immunization strategies.
Abstract

More Related Videos

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions09:02

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions

Published on: September 22, 2023

1.7K
Oral Biofilm Sampling for Microbiome Analysis in Healthy Children10:42

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children

Published on: December 31, 2017

17.4K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
46
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
458
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
243
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
435
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
56